These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2457)

  • 41. Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide.
    Sahu A; Xu B; Kalra SP
    Endocrinology; 1994 Feb; 134(2):529-36. PubMed ID: 7507825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence that a short-lived effect of copper leads to amplification of prostaglandin E2 stimulation of the release of gonadotropin-releasing hormone from median eminence explants.
    Barnea A; Cho G; Colombani-Vidal M
    Endocrinology; 1986 Sep; 119(3):1254-61. PubMed ID: 3525128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostaglandin-induced release of anterior pituitary hormones: structure-activity relationships.
    Warberg J; Eskay RL; Porter JC
    Endocrinology; 1976 May; 98(5):1135-41. PubMed ID: 1261509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of neurotransmitter receptors mediating changes in LH release induced by electrical stimulation of the dorsal raphe nucleus in the rat.
    Johnson JH; Kitts CS
    J Neurosci Res; 1991 Aug; 29(4):520-6. PubMed ID: 1665188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of action of dopamine on the in vitro release of gonadotropin-releasing hormone.
    Jarjour LT; Handelsman DJ; Raum WJ; Swerdloff RS
    Endocrinology; 1986 Oct; 119(4):1726-32. PubMed ID: 3019641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethanol inhibits luteinizing hormone-releasing hormone release from the median eminence of prepubertal female rats in vitro: investigation of its actions on norepinephrine and prostaglandin-E2.
    Hiney JK; Dees WL
    Endocrinology; 1991 Mar; 128(3):1404-8. PubMed ID: 1999162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect and possible mode of action of alpha-melanocyte-stimulating hormone on gonadotropin release in the ovariectomized rat: an in vivo and in vitro analysis.
    Khorram O; DePalatis LR; McCann SM
    Endocrinology; 1984 Jan; 114(1):227-33. PubMed ID: 6418525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of amphetamine anorexia.
    Leibowitz SF
    Brain Res; 1975 Nov; 98(3):529-45. PubMed ID: 1182535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of cholinergic, adrenergic, and serotonergic drugs on the afternoon surge of plasma prolactin in ovariectomized, estrogen-treated rats.
    Subramanian MG; Gala RR
    Endocrinology; 1976 Apr; 98(4):842-8. PubMed ID: 1278094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for adrenergic mediation of cholinergic inhibition of prolactin release.
    Grandison L; Meites J
    Endocrinology; 1976 Sep; 99(3):775-9. PubMed ID: 954668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of manipulation of brain dopaminergic or serotoninergic systems on basal pulsatile LH release and perisuprachiasmatic-induced suppression of pulsatile LH release in ovariectomized rats.
    Gallo RV
    Neuroendocrinology; 1980 Sep; 31(3):161-7. PubMed ID: 6158013
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of PGE2 and colchicine on the intestinal fluid volume.
    Beubler E; Lembeck F; Schweditsch M
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):195-9. PubMed ID: 273148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of the cholinergic system and growth hormone release in the dog: functional interactions with other neurotransmitters.
    Betti R; Casanueva FF; Cella SG; Müller EE
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):36-43. PubMed ID: 2982238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Release of prostaglandin E2 from brain of cat: II. In vivo studies on the effects of adrenergic, cholinergic and dopaminergic agonists and antagonists.
    Navarro E; Romero SD; Yaksh TL
    Neuropharmacology; 1988 Oct; 27(10):1067-72. PubMed ID: 2907118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Failure of a serotonergic receptor-blocking drug to change the twenty-four-hour luteinizing hormone secretory pattern in women.
    Kapen S; Vagenakis A; Braverman L
    J Clin Endocrinol Metab; 1980 Aug; 51(2):302-6. PubMed ID: 7400299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of neurotransmitters in mediating copulation-induced ovulation in the rat.
    Leipheimer RE; Condon TP; Curry JJ
    J Endocrinol; 1984 Mar; 100(3):361-5. PubMed ID: 6142075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of dopaminergic and noradrenergic receptors in human TSH and LH release.
    Jacobs D; Silverstone T; Rees L
    Int Clin Psychopharmacol; 1989 Apr; 4(2):149-60. PubMed ID: 2545773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure to monoaminergic and cholinergic receptor blockers to prevent prostaglandin E2-induced luteinizing hormone release.
    Harms PG; Ojeda SR; McCann
    Endocrinology; 1976 Feb; 98(2):318-23. PubMed ID: 2457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure of neurotransmitter blockers to alter PGE2-induced LH release.
    Jyujo T; Sato T
    Endocrinol Jpn; 1977 Aug; 23(4):281-7. PubMed ID: 200413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further studies on prostaglandin E2 (PGE2)-induced gonadotropin release: comparison with the effect of 15-methyl PGE2, PGAs, PGBs and prostaglandin endoperoxide analogs.
    Ojeda SR; Jameson HE; McCann SM
    Prostaglandins; 1976 Aug; 12(2):281, 301. PubMed ID: 959591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.